| Product Code: ETC9690173 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Thailand Neuroendocrine Tumors Market Overview |
3.1 Thailand Country Macro Economic Indicators |
3.2 Thailand Neuroendocrine Tumors Market Revenues & Volume, 2021 & 2031F |
3.3 Thailand Neuroendocrine Tumors Market - Industry Life Cycle |
3.4 Thailand Neuroendocrine Tumors Market - Porter's Five Forces |
3.5 Thailand Neuroendocrine Tumors Market Revenues & Volume Share, By Classification, 2021 & 2031F |
3.6 Thailand Neuroendocrine Tumors Market Revenues & Volume Share, By Site, 2021 & 2031F |
3.7 Thailand Neuroendocrine Tumors Market Revenues & Volume Share, By Grade, 2021 & 2031F |
3.8 Thailand Neuroendocrine Tumors Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.9 Thailand Neuroendocrine Tumors Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.10 Thailand Neuroendocrine Tumors Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.11 Thailand Neuroendocrine Tumors Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Thailand Neuroendocrine Tumors Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of neuroendocrine tumors in Thailand |
4.2.2 Advancements in diagnostic technologies for early detection and treatment |
4.2.3 Growing awareness among healthcare professionals and patients about neuroendocrine tumors |
4.3 Market Restraints |
4.3.1 Limited access to specialized healthcare facilities for neuroendocrine tumor diagnosis and treatment in certain regions of Thailand |
4.3.2 High treatment costs associated with neuroendocrine tumors management |
4.3.3 Lack of standardized treatment guidelines for neuroendocrine tumors in Thailand |
5 Thailand Neuroendocrine Tumors Market Trends |
6 Thailand Neuroendocrine Tumors Market, By Types |
6.1 Thailand Neuroendocrine Tumors Market, By Classification |
6.1.1 Overview and Analysis |
6.1.2 Thailand Neuroendocrine Tumors Market Revenues & Volume, By Classification, 2021- 2031F |
6.1.3 Thailand Neuroendocrine Tumors Market Revenues & Volume, By Functional Net, 2021- 2031F |
6.1.4 Thailand Neuroendocrine Tumors Market Revenues & Volume, By Non-Functional Net, 2021- 2031F |
6.2 Thailand Neuroendocrine Tumors Market, By Site |
6.2.1 Overview and Analysis |
6.2.2 Thailand Neuroendocrine Tumors Market Revenues & Volume, By Lung, 2021- 2031F |
6.2.3 Thailand Neuroendocrine Tumors Market Revenues & Volume, By Pancreas, 2021- 2031F |
6.2.4 Thailand Neuroendocrine Tumors Market Revenues & Volume, By Gastrointestinal Tract (GI), 2021- 2031F |
6.2.5 Thailand Neuroendocrine Tumors Market Revenues & Volume, By Appendicular, 2021- 2031F |
6.3 Thailand Neuroendocrine Tumors Market, By Grade |
6.3.1 Overview and Analysis |
6.3.2 Thailand Neuroendocrine Tumors Market Revenues & Volume, By Grade 1, 2021- 2031F |
6.3.3 Thailand Neuroendocrine Tumors Market Revenues & Volume, By Low-Grade Tumor, 2021- 2031F |
6.3.4 Thailand Neuroendocrine Tumors Market Revenues & Volume, By Grade 2, 2021- 2031F |
6.3.5 Thailand Neuroendocrine Tumors Market Revenues & Volume, By Intermediate-Grade Tumor, 2021- 2031F |
6.3.6 Thailand Neuroendocrine Tumors Market Revenues & Volume, By Grade 3, 2021- 2031F |
6.3.7 Thailand Neuroendocrine Tumors Market Revenues & Volume, By High-Grade Tumor, 2021- 2031F |
6.4 Thailand Neuroendocrine Tumors Market, By Type |
6.4.1 Overview and Analysis |
6.4.2 Thailand Neuroendocrine Tumors Market Revenues & Volume, By Diagnosis, 2021- 2031F |
6.4.3 Thailand Neuroendocrine Tumors Market Revenues & Volume, By Treatment, 2021- 2031F |
6.5 Thailand Neuroendocrine Tumors Market, By Product |
6.5.1 Overview and Analysis |
6.5.2 Thailand Neuroendocrine Tumors Market Revenues & Volume, By Somatostatin Analogs, 2021- 2031F |
6.5.3 Thailand Neuroendocrine Tumors Market Revenues & Volume, By Targeted Therapy, 2021- 2031F |
6.5.4 Thailand Neuroendocrine Tumors Market Revenues & Volume, By Tyrosine Kinase Inhibitors, 2021- 2031F |
6.5.5 Thailand Neuroendocrine Tumors Market Revenues & Volume, By mTOR Inhibitors, 2021- 2031F |
6.5.6 Thailand Neuroendocrine Tumors Market Revenues & Volume, By Chemotherapy, 2021- 2031F |
6.5.7 Thailand Neuroendocrine Tumors Market Revenues & Volume, By Antimetabolites, 2021- 2031F |
6.5.8 Thailand Neuroendocrine Tumors Market Revenues & Volume, By Natural Products, 2021- 2031F |
6.5.9 Thailand Neuroendocrine Tumors Market Revenues & Volume, By Natural Products, 2021- 2031F |
6.6 Thailand Neuroendocrine Tumors Market, By Route of Administration |
6.6.1 Overview and Analysis |
6.6.2 Thailand Neuroendocrine Tumors Market Revenues & Volume, By Oral, 2021- 2031F |
6.6.3 Thailand Neuroendocrine Tumors Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.7 Thailand Neuroendocrine Tumors Market, By End User |
6.7.1 Overview and Analysis |
6.7.2 Thailand Neuroendocrine Tumors Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.7.3 Thailand Neuroendocrine Tumors Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.7.4 Thailand Neuroendocrine Tumors Market Revenues & Volume, By Home Healthcare, 2021- 2031F |
6.7.5 Thailand Neuroendocrine Tumors Market Revenues & Volume, By Home Healthcare, 2021- 2031F |
6.7.6 Thailand Neuroendocrine Tumors Market Revenues & Volume, By Others, 2021- 2031F |
6.8 Thailand Neuroendocrine Tumors Market, By Distribution Channel |
6.8.1 Overview and Analysis |
6.8.2 Thailand Neuroendocrine Tumors Market Revenues & Volume, By Direct Tender, 2021- 2031F |
6.8.3 Thailand Neuroendocrine Tumors Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.8.4 Thailand Neuroendocrine Tumors Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.8.5 Thailand Neuroendocrine Tumors Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.8.6 Thailand Neuroendocrine Tumors Market Revenues & Volume, By Other, 2021- 2031F |
7 Thailand Neuroendocrine Tumors Market Import-Export Trade Statistics |
7.1 Thailand Neuroendocrine Tumors Market Export to Major Countries |
7.2 Thailand Neuroendocrine Tumors Market Imports from Major Countries |
8 Thailand Neuroendocrine Tumors Market Key Performance Indicators |
8.1 Average time from diagnosis to treatment initiation for neuroendocrine tumors patients in Thailand |
8.2 Number of healthcare facilities offering specialized care for neuroendocrine tumors in Thailand |
8.3 Patient satisfaction rates with neuroendocrine tumor treatment services in Thailand |
9 Thailand Neuroendocrine Tumors Market - Opportunity Assessment |
9.1 Thailand Neuroendocrine Tumors Market Opportunity Assessment, By Classification, 2021 & 2031F |
9.2 Thailand Neuroendocrine Tumors Market Opportunity Assessment, By Site, 2021 & 2031F |
9.3 Thailand Neuroendocrine Tumors Market Opportunity Assessment, By Grade, 2021 & 2031F |
9.4 Thailand Neuroendocrine Tumors Market Opportunity Assessment, By Type, 2021 & 2031F |
9.5 Thailand Neuroendocrine Tumors Market Opportunity Assessment, By Product, 2021 & 2031F |
9.6 Thailand Neuroendocrine Tumors Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.7 Thailand Neuroendocrine Tumors Market Opportunity Assessment, By End User, 2021 & 2031F |
9.7 Thailand Neuroendocrine Tumors Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Thailand Neuroendocrine Tumors Market - Competitive Landscape |
10.1 Thailand Neuroendocrine Tumors Market Revenue Share, By Companies, 2024 |
10.2 Thailand Neuroendocrine Tumors Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here